Indivior Pharmaceuticals Ratios (2021-2026) | INDV

Ratios Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 82.81%82.76%82.16%84.58%81.88%83.03%82.25%86.62%73.58%78.50%83.22%83.08%82.78%73.25%81.56%87.38%
EBT Margin (Quarter) 26.24%23.28%-106.22%22.92%22.46%-66.79%20.82%25.70%-40.47%9.77%12.75%22.18%20.53%11.78%22.63%36.28%
EBIT Margin (Quarter) 28.51%24.14%-107.05%22.53%22.10%-67.53%20.48%22.89%-39.46%11.40%15.44%24.81%23.84%13.69%22.63%43.22%
EBITDA Margin (Quarter) 28.51%24.14%-107.05%22.53%22.10%-67.53%20.48%20.77%-32.44%11.40%15.44%18.42%6.62%13.69%22.63%43.22%
Operating Margin (Quarter) 28.51%24.14%-107.05%22.53%22.10%-67.53%20.48%22.89%-39.46%11.40%15.44%24.81%23.84%13.69%22.63%43.22%
Net Margin (Quarter) 30.77%28.88%-136.51%28.46%30.80%-83.76%23.21%21.83%-32.78%7.17%7.05%18.05%5.96%13.38%28.49%28.08%
FCF Margin (Quarter) 0.86%-3.73%-5.93%-3.26%9.59%-105.80%-13.73%28.09%-1.63%-11.07%26.32%46.69%-18.79%-68.44%-9.15%
Efficiency
Inventory Average (Quarter) 136.50M134.00M144.50M167.00M174.50M172.50M165.00M156.00M152.00M154.00M152.50M
Assets Average (Quarter) 1,800.50M1,781.50M1,791.50M1,805.00M1,605.50M1,494.00M1,499.50M1,390.00M1,345.50M1,413.50M1,434.00M1,308.50M1,199.00M
Equity Average (Quarter) -172.50M-221.00M-295.50M-323.50M-311.00M-271.00M-232.00M-152.50M-121.00M
Invested Capital (Quarter) 437.00M309.00M56.00M-161.00M-281.00M-310.00M-4.00M-267.00M-239.00M-189.00M-69.00M-144.00M
Asset Utilization Ratio (Quarter) 0.530.560.580.610.700.770.790.850.870.830.820.951.08
Leverage & Solvency
Interest Coverage Ratio (Quarter) -9.00-7.0032.25-5.70-6.1018.30-6.677.22-13.113.18-3.295.504.803.5813.5019.57
Debt to Equity (Quarter) 2.00-16.00-1.30-0.99-1.15-1.27-1.56-3.26-3.38
Debt Ratio (Quarter) 0.130.140.140.250.240.220.230.270.41
Equity Ratio (Quarter) 0.07-0.01-0.10-0.11-0.18-0.21-0.26-0.21-0.18-0.15-0.08-0.12
Times Interest Earned (Quarter) -9.00-7.0032.25-5.70-6.1018.30-6.677.22-13.113.18-3.295.504.803.5813.5019.57
Valuation
Enterprise Value (Quarter) -1102.00M-931.00M-869.00M-893.00M-741.00M-556.00M-570.00M-731.00M-330.00M-307.00M-302.00M-320.00M-373.00M-510.00M-445.00M-195.00M-175.00M
Return Ratios
Return on Sales (Quarter) 0.00%0.00%-0.01%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter) -0.95%6.01%8.52%61.26%48.40%66.41%79.29%
Return on Invested Capital (Quarter) 0.00%0.01%0.00%0.00%0.00%0.00%-0.01%-0.02%-0.03%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%0.01%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.02%